K. Shimomura, H. Minatogawa, T. Mashiko, H. Arioka, H. Iihara, M. Sugawara, N. Hida, K. Akiyama, S. Nawata, A. Tsuboya, et al. LBA63 Placebo-controlled, double-blinded phase III study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial. Annals of Oncology. 2021. 32. S1339-S1340
Placebo-controlled, double-blinded phase III study comparing dexamethasone on day1 with dexamethason on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial
(ESMO Virtual Congress 2021 2021)
日本乳癌学会
, 日本病院薬剤師会
, 日本在宅薬学会
, 日本緩和医療薬学会
, 日本がんサポーティブケア学会
, 日本臨床腫瘍学会
, JAPAN SOCIETY OF CLINICAL ONCOLOGY
, JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
, 日本臨床腫瘍薬学会